Prognostic Value of Lymphocyte Vascular Density and E-Cadherin in Inflammatory Breast Cancer

Journal of Cancer Therapy
doi 10.4236/jct.2014.514139
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Scientific Research Publishing, Inc,

Related search

E-Cadherin as a Prognostic Indicator in Primary Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
2001English

Nature and Prognostic Significance of Alterations in the DCC and E-Cadherin Genes in Breast Cancer

1999English

Prognostic Value of Cathepsin D in Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
1998English

Prognostic Value of Neutrophil‐to‐lymphocyte Ratio and Platelet‐to‐lymphocyte Ratio for Breast Cancer Patients: An Updated Meta‐analysis of 17079 Individuals

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Exploring the Prognostic Value of the Neutrophil-To-Lymphocyte Ratio in Cancer

Scientific Reports
Multidisciplinary
2019English

E-Cadherin/Ros1 Inhibitor Synthetic Lethality in Breast Cancer

Cancer Discovery
Oncology
2018English

Prognostic Value of Lymphocyte-Activation Gene 3 (LAG3) in Cancer: A Meta-Analysis

Frontiers in Oncology
Cancer ResearchOncology
2019English

The Prognostic Value of Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios for Patients With Lung Cancer

Oncology Letters
Cancer ResearchOncology
2017English

Prognostic Role for Derived Neutrophil-To-Lymphocyte Ratio in Early Breast Cancer

Annals of Oncology
MedicineOncologyHematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy